Project Grant R43HD106857
Award Date
9/1/22
Completion Date
8/31/23
Dollars Obligated
$770K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Temple, TX 76504, USA
Similar Awards
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $485,925 to the University of Massachusetts Boston to develop novel antioxidant compounds for treating preeclampsia, a life-threatening pregnancy complication. The primary goal is to design and synthesize cationic hydrazone antioxidants that can target mitochondria to reduce oxidative stress, improve...
This Project Grant award of $698,750 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop a targeted, placenta-tropic lipid nanoparticle (LNP) platform for delivering therapeutic mRNA cargo to the placenta to treat pre-eclampsia, a serious pregnancy condition. The key products and services to be delivered include: High-throughput screening of a large library of novel...
This $424,373 Project Grant, awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support research to identify and validate transcription factors that control preeclampsia-specific gene expression programs. The project will utilize human trophoblast stem cells as a model system to elucidate the regulatory mechanisms of these "preeclampsia-driver" transcription factors...
This federal Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 (Child Health and Human Development Extramural Research) aims to develop and evaluate water-soluble prodrugs of the novel therapeutic compound AKT-1005 for the treatment of preeclampsia. The $468,540 award to Beth Israel Deaconess Medical Center, Inc. (BIDMC) will fund research to synthesize and screen AKT-1005 prodrugs for improved solubility,...
This $232,500 Project Grant awarded by the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) to Wake Forest University Health Sciences will fund research to establish the neuroprotective actions of the apelinergic axis on the long-term cerebrovascular consequences of preeclampsia. The research aims to improve understanding of the protective role of the apelin/APJ axis in preeclampsia, a hypertensive disorder of...
The National Institute of Child Health and Human Development (NICHD) has awarded a $423,985 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the University of Illinois to develop a novel non-invasive monitoring system for detecting placental dysfunction and associated pregnancy complications. The funding will support research to utilize extracellular vesicles (EVs) circulating in maternal blood as biomarkers, using a "target recycling...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $760,950 to support research focused on employing biologics to probe G protein-coupled receptor (GPCR) signaling in maternal and fetal health. The key objectives are to: 1) characterize the mechanisms antibody fragments use to suppress angiotensin II type I receptor (AT1R)...
This $550,000 Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development and validation of a non-invasive, multiplex blood test for the early detection of preeclampsia, a serious pregnancy complication. The project aims to advance the detection of vascular dysfunction, particularly preeclampsia, by optimizing a blood test that targets disease-inducing signaling proteins on the surface of...
This $717,285 Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will fund a large-scale investigation of the vaginal ecosystem and its potential role in preeclampsia. The project aims to uncover the microbial, metabolomic, and immune properties of the vaginal microbiome that may indicate, predispose to, or contribute to the development of preeclampsia, a serious...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $148,880.00 to the University of Mississippi Medical Center to investigate the long-term effects of preeclampsia (PE) on offspring. The key research objectives are to: 1) Test the hypothesis that B cells from PE women produce autoantibodies that contribute to hypertension,...